Market Place
Sourcing Support
Granules India gets USFDA nod for generic drug
17 Dec 2024 //
PRESS RELEASE
Granules`s Generics Lisdexamfetamine Receives Approval in US
16 Dec 2024 //
FDA
Granules India updates on FDA inspection at Gagillapur Facility
04 Dec 2024 //
PRESS RELEASE
Granules’ net zero commitment approved by SBTi
30 Nov 2024 //
PRESS RELEASE
Granules India appoints Ovais Sarmad as sustainability advisor
18 Nov 2024 //
EXPRESSPHARMA
Granules India presented with Golden Peacock Award for sustainability
15 Nov 2024 //
EXPRESSPHARMA
Granules India Q2 FY25 PAT drops 5% YoY to Rs. 97 Cr
06 Nov 2024 //
PRESS RELEASE
Granules India gets USFDA nod for generic Glycopyrrolate oral solution
20 Aug 2024 //
PRESS RELEASE
Granules India gains ANDA approval for Trazodone tablets
09 Aug 2024 //
PRESS RELEASE
Granules Quarterly Results- FY25-Q1
30 Jul 2024 //
PRESS RELEASE
Granules India`s Q1 profit nearly triples on strong demand
30 Jul 2024 //
REUTERS
Annual Financial Results – FY24
15 May 2024 //
PRESS RELEASE
Granules India Announced ANDA Approval for Colchicine Capsules
30 Apr 2024 //
PRESS RELEASE
Granules India Annual Financial Results – FY24
30 Apr 2024 //
PRESS RELEASE
Granules India’s Vizag facility completes US FDA inspection with zero 483
15 Apr 2024 //
EXPRESSPHARMA
Granules India Unit V facility in Andhra Pradesh`s Anakapally gets Zero 483
12 Apr 2024 //
CNBC
Granules, NIPER-Mohali ink pact to establish centre of excellence
01 Feb 2024 //
THEHINDU
Paracetamol maker Granules Quarterly Results-FY24-Q3
23 Jan 2024 //
PRESS RELEASE
Granules India Generic gets USFDA nod for Pantoprazole Sodium
13 Dec 2023 //
PRESS RELEASE
Granules India Received ANDA Approval for Sildenafil for Oral Suspension.
03 Dec 2023 //
PRESS RELEASE
Granules` Generic Sildenafil Citrate Receives Approval in the U.S.
01 Dec 2023 //
FDA
Quarterly Results-FY24-Q2
09 Nov 2023 //
PRESS RELEASE
Granules Received ANDA Approval for Esomeprazole Magnesium Del-Release Capsules
19 Oct 2023 //
PRESS RELEASE
Granules gets FDA nod for generic drug used for treatment of heartburn
19 Oct 2023 //
ECONOMIC TIMES
Granules India Received ANDA Approval for Losartan and HCL Tablets
30 Sep 2023 //
PRESS RELEASE
Quarterly Results -FY24- Q1
09 Aug 2023 //
PRESS RELEASE
Delivering Quality Drugs – Priyanka chigurupati
09 Aug 2023 //
PRESS RELEASE
Paracetamol maker Granules India` Q1 profit hurt by cyber attack disruptions
09 Aug 2023 //
REUTERS
Granules` Generic Metoprolol Receives Approval in the U.S.
07 Aug 2023 //
FDA
Granules Pharma Successfully Completes USFDA (PADE) Inspection Zero Observation
04 Aug 2023 //
PRESS RELEASE
The Role Of ESG In Future Growth Words By Dr. Krishna Prasad Chigurupati
19 Jul 2023 //
MARKSMENDLY
Granules India announces US FDA approval OTC (Store brand) equivalent of Advil
14 Jul 2023 //
PRESS RELEASE
A Transformative Growth Story – 28th, April, 2023
14 Jul 2023 //
PRESS RELEASE
Ms. Priyanka Chigurupati wins Business World Healthcare 40 under 40 award
14 Jul 2023 //
BWHEALTHCAREWORLD
Increased competition, US gov lower drug prices , pricing pressure: Priyanka
14 Jul 2023 //
FORBESINDIA
Successfully Completes Two US FDA Audits of Two Weeks Vizag Zero Observations
30 Jun 2023 //
PRESS RELEASE
Granules India and Central Bureau of Narcotics unite to tackle drug abuse
29 Jun 2023 //
INDIANPHARMAPOST
Paracetamol maker Granules flags significant operations hit from cyber attack
29 Jun 2023 //
REUTERS
Granules India and Central Bureau of Narcotics Unite to Tackle Drug Abuse
28 Jun 2023 //
PRESS RELEASE
Granules Receives ANDA Approval for Levetiracetam Tablets in record 9 months
14 Jun 2023 //
PRESS RELEASE
Granules India Received ANDA Approval for Metoprolol Succinate ER Tablets
13 Jun 2023 //
PRESS RELEASE
Granules` Generic Levetiracetam Receives Approval in the U.S.
13 Jun 2023 //
FDA
Granules` Generic Metoprolol Succinate Receives Approval in the U.S.
12 Jun 2023 //
FDA
Granules reports `information security incident`; isolates impacted IT assets
25 May 2023 //
ECONOMIC TIMES
Granules India Limited Received ANDA Approval for Venlafaxine ER Capsules
19 May 2023 //
PRESS RELEASE
Quarterly Results-FY23-Fourth Quarter
16 May 2023 //
PRESS RELEASE
Indian pharma firm Granules opens packaging facility in US` Virginia
30 Mar 2023 //
ECONOMIC TIMES
Granules Consumer Health Inc., inaugurates its Packaging Facility in the U.S.
29 Mar 2023 //
PRESS RELEASE
Granules India receives USFDA approval for generic gabapentin tablets
29 Mar 2023 //
ECONOMIC TIMES
GCH concluded U S FDA audit
21 Mar 2023 //
PRESS RELEASE
Granules India Limited Received ANDA Approval for Losartan Potassium Tablets
27 Feb 2023 //
PRESS RELEASE
Losartan Tabs Press Release (002)
27 Feb 2023 //
PRESS RELEASE
Granules gets FDA nod to market generic medication to treat high blood pressure
27 Feb 2023 //
ECONOMIC TIMES
Granules Pharma Receives ANDA Approval for Amphetamine Mixed Salts ER Capsules
24 Jan 2023 //
PRESS RELEASE
Quarterly Results -FY23-Third Quarter
24 Jan 2023 //
PRESS RELEASE
Granules gets USFDA`s nod for Amphetamine capsules
24 Jan 2023 //
ECONOMIC TIMES
USFDA issues form-483 with three observations to Granules India`s Telangana unit
16 Jan 2023 //
CNBCTV18
Granules Enters into a Strategic Partnership With Greenko ZeroC To Enable
03 Jan 2023 //
PRESS RELEASE
Granules partners with Greenko ZeroC to enable carbon-free energy
03 Jan 2023 //
EXPRESS PHARMA
